Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GermanyBack to Germany

Clinical trials in Weiden I.D.Opf.

5 clinical trials in Weiden I.D.Opf., Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Weiden I.D.Opf. at a glance
5
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Weiden I.D.Opf.

Open in trial search

Breast cancer+1

Recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Sargramostim
  • Sponsor:Greenwich LifeSciences Inc.

Plasma cell myeloma refractory

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Celgene Corp.

Hormone receptor positive breast cancer+2

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Institut fuer Frauengesundheit GmbH

Hormone receptor positive HER2 negative breast cancer

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Novartis Pharma AG

Chronic lymphocytic leukaemia

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:University Of Cologne

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Weiden I.D.Opf.

What the registry says about research in the country

01 Weiden I.D.Opf.
Neoplasms
Clinical trial activity in Weiden I.D.Opf. is focused on neoplasms, with all currently recruiting studies centered on cancer research. The work highlights efforts to improve treatment outcomes and better understand how different cancer therapies perform in real-world patient groups. Breast cancer research in HR-positive, HER2-negative disease Studies in advanced hormone receptor-positive breast cancer Trials for chronic lymphocytic leukemia Research in relapsed or refractory multiple myeloma These studies aim to assess how well new or combined cancer treatments can extend survival, delay disease progression, and support better disease control.
Breast Cancer
A major part of the research landscape involves breast cancer, especially HR-positive, HER2-negative disease. The trials are designed to evaluate treatment effectiveness and help refine care for both early and advanced stages. Early breast cancer Advanced breast cancer Endocrine therapy combinations Measures such as invasive breast cancer-free survival The goal is to determine whether new treatment strategies can improve long-term control of disease and reduce the risk of recurrence.
Hematologic Malignancies
The city also hosts trials in hematologic malignancies, including multiple myeloma and chronic lymphocytic leukemia. This research focuses on comparing treatment approaches for patients whose cancer has returned or is harder to treat. Relapsed or refractory multiple myeloma Previously untreated chronic lymphocytic leukemia Testing new combination therapies Evaluating progression-free survival and overall disease control These studies aim to identify more effective options that can slow disease progression and improve outcomes for patients with blood cancers.
Back to GermanyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.